PTC Therapeutics, Inc. (PTCT) Social Stream
Ptc Therapeutics Inc (PTCT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Ptc Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
PTCT's average price target has moved down $6.44 over the prior 16 months.
Over the past 121 days, PTCT's average upside potential has been 44.61%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PTCT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
PTCT's average broker recommendation rating improved by 0.45 over the prior 151 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PTCT as an investment opportunity.
- Ptc Therapeutics Inc's variance in analysts' estimates is lower than -225.7% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Ptc Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 78.6% of them.
- In the context of Pharmaceutical Products stocks, Ptc Therapeutics Inc's average analyst price target is higher than 290.51% of them.
- PTCT has a greater number of analysts covering the stock than 276.08% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, PRTA, PRLD, and PRAX are the three stocks most similar to Ptc Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!